This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Syracuse University, The State University of New York. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2014
Title: The Innovative Contributions of Donna J Osterhout
Introduction
Donna J Osterhout is a notable inventor based in East Syracuse, NY (US). She has made significant strides in the field of biomedical engineering, particularly in the treatment of spinal cord injuries. Her innovative approach combines advanced materials with therapeutic agents to enhance recovery outcomes for patients.
Latest Patents
Osterhout holds a patent for a "Nanosphere/microsphere delivery system for the treatment of spinal cord injury." This invention involves a formulation that includes injectable biodegradable nanospheres and/or microspheres designed to deliver chondroitinase ABC (cABC) or its functional derivatives. The system aims to treat both acute and chronic spinal cord injuries in mammals. The biodegradable formulation releases cABC in a time-released manner at the injury site, promoting axon regrowth and behavioral recovery. The invention also allows for modifications to the surface of the biodegradable polymer matrix to target specific scar sites, enhancing the effectiveness of the treatment.
Career Highlights
Throughout her career, Osterhout has worked with prestigious institutions such as the State University of New York and Syracuse University. Her work has contributed to advancements in medical treatments and has garnered attention in the scientific community.
Collaborations
Osterhout has collaborated with notable colleagues, including Julie M Hasenwinkel and Dennis J Stelzner. These partnerships have fostered innovation and have played a crucial role in the development of her patented technologies.
Conclusion
Donna J Osterhout's contributions to the field of spinal cord injury treatment through her innovative delivery systems exemplify the impact of her work on medical science. Her dedication to improving patient outcomes through research and collaboration continues to inspire advancements in biomedical engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile